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which occur in the interpretation of results are not 
mentioned. The first half of the book reads rather like 
an encyclopaedia and so partly fails to communicate 
underlying concepts. A regrettable aspect is the pres- 
entation of several data-free sketches, e.g., pH- and 
temperature-dependence. Experimental results would 
be more suitable. 
Aspiring enzymologists would be better advised to 
read Alan Fersht’s excellent book which demonstrates 
many of the virtues lacking in the first half of this 
book. However, having regard to the reader with wider 
interests, e.g., the medical or industrial biochemist 
then this book might prove very useful as a convenient 
handbook since it is an adequate source of references. 
It is thus to this type of reader that this book is 
recommended, in particular the laudable chapters 
mentioned above. 
A factor that casued some irritaion to the reviewer 
was the refusal of the book to lie open (flat) upon my 
desk; indeed a few pages were liberated in my quite 
gentle attempts to persuade it to do so. 
C. W. Wharton 
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Antibiotics Z was published in 1967, was edited by 
D. Gottlieb and P. D. Shaw and contained a series of 
reviews concerning the actions of antibiotics. Further 
volumes have since appeared culminating in the pre- 
sent extended edition. Antibiotics V include 42 
independent contributions and considers awide selec- 
tion of compounds. Part 1 was structured to deal with 
the modes of action of antibacterial gents whereas 
part 2 deals with substances inhibiting eukaryotes or 
viruses. As stated in the preface, however, the separa- 
tion is somewhat arbitrary since many of the sub- 
stances cited are potent inhibitors of function in both 
pro- and eukaryotes. Furthermore, in the selection of 
compounds ynthetic drugs and plant alkaloids have 
been included along with antibiotics per se. 
Inevitably, many topics are not considered. For 
example, the Editor has chosen to exclude any cover- 
age of the lactam antibiotics, the penicillins and 
cephalosporins, and he goes to some lengths in the 
preface to justify this decision. However, this partic- 
ular aspect of Antibiotics V is to me unsatisfactory. 
Thus certain members of the large and interesting 
group of naturally-occurring ucleoside and nucleo- 
tide analogues are featured incuding, for examples, 
9./3-D-arabinofuranosyladenine, showdomycin, 
8.azaguanine and 5iodo-2’deoxyuridine. The criteria 
used for selection are obscure, certainly to this 
reviewer. Furthermore two other books have recently 
appeared where these and related compounds have 
been well cited - viz. Nucleosides as Biological Probes 
by R. J. Suhadolnik (Wiley Interscience, 1979) and 
Nucleoside AnaZomes edited by R. T. Walker, E 
E. DeClercq and F. Eckstein (Plenum Press, 1979). 
While I accept hat selection of topics for inclusion in 
the present wo volumes must have been a difficult 
task, I can fmd no real evidence of an overall grand 
plan. The Editor concedes that there is a problem in 
grouping the contributions into logically coherent 
sections and settles for an alphabetical presentation. 
However, it does not help to have an article on the 
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peptidyl transferase inhibitor chloramphenicol pre- 
ceded by one on bicyclomycin, a potent inhibitor of 
the biosynthesis of bound form lipoproteins, and fol- 
lowed by one on the antituberculous drug etham- 
butol. Surely the ribosomal inhibitors considered in 
volume 1 and including chloramphenical, sparsomy- 
tin, streptomycin, tetracycline, thiostrepton, tiamulin 
and pleuromutilin should have been grouped together. 
This is particularly relevant for chloramphenicol and 
lincomycin (also featured in this volume) which have 
several important features in common. These two 
compounds could usefully have been subjected to a 
comparative analysis. More surprising still is the inclu- 
sion in volume 1 of an article on the polypeptide anti- 
biotics phenomycin and enomycin. These two com- 
pounds can hardly be classed as antibacterial agents 
since they are apparently selectively toxic towards 
eukaryotic ribosomes. 
Bleomycin 
Chemical, Biochemical, and Biological Aspects 
Edited by S. M. Hecht 
Springer-Verlag; Berlin, Heidelberg, New York, 1979 
xii + 352 pages. DM 79.00, $34.50, E20.55 
As a record of the Proceedings of a joint US-Japan- 
ese symposium held in Honolulu 1978, this book 
summarises current work from the two countries most 
actively engaged in research into the mechanisms of 
action of bleomycin. The bleomycins are a complex 
of low-molecular-weight glycopeptide antibiotics 
isolated from cultures of Streptomyces. They differ 
from each other in their terminal amine moiety, but 
all display to some degree anti-tumour, anti-viral and 
anti-bacterial properties. The drug was first discovered 
by Professor Umezawa, an active participant at this 
symposium, who has maintained a close supervisory 
role over all aspects of bleomycin research. This drug 
is now used almost universally in oncology centres 
for the treatment of squamous cell carcinoma, Hodg- 
kin’s lymphoma and testicular tumours. 
After introductory reviews, three chapters describe 
recent synthetic and biosynthetic work on bleomycin 
In spite of these considerations, however, Anti- 
biotics V contains some excellent individual contri- 
butions although inevitably a few lame ducks are 
also in evidence. I wonder though if Professor Hahn 
might rethink this strategy? As he says in the preface 
to volume 1 this field no longer possesses the relative 
homogeneity in the level of knowledge which still 
existed in 1967 when Antibiotics I was published. 
Perhaps future volumes really should contain a set 
number of concise but detailed review articles each 
concentrating on a group of inhibitors that affect 
processes within a closely related area. Individual 
compounds can then be carefully selected from each 
set and subjected to more extensive coverage. At the 
least this might provide a coherent picture instead of 
the current fragmented approach. 
Michael Cannon 
resulting in certain revisions to its structure. Analysis 
of bleomycin using liquid chromatography and NMR 
follow as two rather isolated chapters particularly as 
a section at the end of the book is devoted to practical 
assay methods. 
Two distinct chemical properties of the drug define 
its biological activity; an ability to bind to DNA and a 
high affinity for certain divalent metal ions. Chelation 
mechanistics and their importance to structure and 
activity are discussed with reference to copper, iron, 
zinc and cobalt complexes. The ability of the bleo- 
mycin-metal complex to absorb metabolically derived 
dioxygen is noted as a unique feature shared only by 
the two naturally occuring compounds, haem and 
vitamin Brz. Bleomycin-mediated damage to linear 
duplex DNA can be assessed by measuring the release 
of either bases or malondialdehyde (techniques are 
given in the assay section). In order that DNA chain 
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